BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
Indications
/
Essential Hypertension
Essential Hypertension
26 competing products in clinical development for Essential Hypertension.
Pipeline by Phase
Pre-clinical
3
Phase 1
1
Phase 2
1
Phase 3
17
Approved
4
All Products (26)
Product
Company
Stage
Status
Hype
Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg + Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mg
Yuhan
Approved
Active
47
olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessary
Daiichi Sankyo
Approved
Completed
43
olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessary
Daiichi Sankyo
Approved
Completed
43
AZM X mg + AML Y mg + AZM X mg + AML Y' mg + AZM X' mg + AML Y mg + AZM X' mg + AML Y' mg + AZM X mg + AZM X' mg + AML Y mg + AML Y' mg
Celltrion
Phase 3
Completed
40
olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets and placebo + olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets + olmesartan medoxomil/hydrochlorothiazide tablets + olmesartan medoxomil/hydrochlorothiazide tablets
Daiichi Sankyo
Phase 3
Completed
40
olmesartan medoxomil + hydrochlorothiazide, if necessary + losartan + hydrochlorothiazide, if necessary
Daiichi Sankyo
Phase 3
Completed
40
CS8635 20/5/12.5mg and placebo + Olmetec® Plus 20/12.5mg and placebo
Daiichi Sankyo
Phase 3
Completed
40
olmesartan medoxomil + amlodipine + hydroclororthiazide + placebo + Olmesartan medoxomil + amlodipine + hydrochlorothiazide + placebo + olmesartan medoxomil + amlodipine + hydroclororthiazide + olmesartan medoxomil + amlodipine + hydroclororthiazide + olmesartan medoxomil + amlodipine + hydroclororthiazide + olmesartan medoxomil + amlodipine + olmesartan medoxomil + amlodipine + olmesartan medoxomil + amlodipine
Daiichi Sankyo
Phase 3
Completed
40
Olmesartan medoxomil + Atenolol + Hydrochlorothiazide + olmesartan medoxomil + atenolol
Daiichi Sankyo
Phase 3
Completed
40
CS-3150 + Eplerenone
Daiichi Sankyo
Phase 3
Completed
40
olmesartan medoxomil + losartan potassium
Daiichi Sankyo
Phase 3
Completed
40
Olmesartan medoxomil 40 mg - Amlodipine 10 mg + Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 12.5mg + Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 25mg + OLM 40mg-AML 10mg-Hydrochlorothiazide 12.5mg + OLM 40mg-AML 10mg-Hydrochlorothiazide 12.5mg + OLM 40mg-AML 10mg-Hydrochlorothiazide 25mg
Daiichi Sankyo
Phase 3
Completed
40
Olmesartan medoxomil + Losartan + Furosemide oral tablets
Daiichi Sankyo
Phase 3
Completed
40
olmesartan medoxomil (OM)+ hydrochlorothiazide (HCTZ) tablets + olmesartan medoxomil (OM)/ hydrochlorothiazide (HCTZ) 20mg/25mg
Daiichi Sankyo
Phase 3
Completed
40
olmesartan medoxomil + amlodipine
Daiichi Sankyo
Phase 3
Completed
40
olmesartan medoxomil + amlodipine + hydrochlorothiazide
Daiichi Sankyo
Phase 3
Completed
40
CS-3150
Daiichi Sankyo
Phase 3
Completed
40
olmesartan medoxomil + losartan potassium
Daiichi Sankyo
Phase 3
Completed
40
olmesartan medoxomil + hydrochlorothiazide + olmesartan medoxomil
Daiichi Sankyo
Phase 3
Completed
40
olmesartan medoxomil + olmesartan medoxomil oral tablets, hydrochlorothiazide oral tablets
Daiichi Sankyo
Phase 3
Completed
40
CS-3150 + placebo + eplerenone
Daiichi Sankyo
Phase 2
Completed
35
Atenolol + olmesartan medoxomil
Daiichi Sankyo
Approved
Terminated
35
Telmisartan/Amlodipine/Chlorthalidone(Truset)
Yuhan
Pre-clinical
Active
30
L04RD1 + L04TD3
Celltrion
Phase 1
Completed
29
Azilsartan Medoxomil
Celltrion
Pre-clinical
Completed
26
CS-3150 + olmesartan medoxomil
Daiichi Sankyo
Pre-clinical
Completed
26